PRX3 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

108 results for “PRX3”

Trials

View all 57 →

Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer

38 participants · First posted Mar 16, 2017

Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate Cancer

18 participants · First posted Jul 16, 2015

Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia

92 participants · First posted Apr 29, 2009

Drugs

View all 42 →

PRL3-zumab

PRX-ASS1

PRX-167700

News

New Drug RSO-021 Shows Promise in Mesothelioma Trial by Targeting Cancer's Energy System

Singapore's PRL3-zumab Shows Promise in Phase II Trial for Treatment-Resistant Solid Tumors

Singapore-Developed Cancer Drug PRL3-zumab Shows Promise for Treating Vision Loss in AMD and Diabetic Retinopathy

Page 1 of 11